Boston Scientific Corp (BSX)

[mlkrborn]

Boston Scientific to acquire BridgePoint Medical, Inc.; transaction is expected to have an immaterial impact on GAAP and adjusted earnings in 2012 and 2013 and be modestly accretive thereafter (BSX) 5.75 : Co has signed a definitive agreement to acquire BridgePoint Medical, Inc., a privately held company based in Minneapolis, Minnesota. BridgePoint Medical has developed a proprietary, catheter-based system to treat coronary chronic total occlusions. The transaction is expected to close in the fourth quarter of 2012 subject to customary closing conditions. The transaction is expected to have an immaterial impact on GAAP and adjusted earnings in 2012 and 2013 and be modestly accretive thereafter. Financial terms of the transaction are not being disclosed.